Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1007/s00380-021-01835-w

http://scihub22266oqcxt.onion/10.1007/s00380-021-01835-w
suck pdf from google scholar
33743048!7980755!33743048
unlimited free pdf from europmc33743048    free
PDF from PMC    free
html from PMC    free

Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33743048&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215

suck abstract from ncbi

pmid33743048      Heart+Vessels 2021 ; 36 (10): 1474-1483
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Impact of the COVID-19 outbreak on hospitalizations and outcomes in patients with acute myocardial infarction in a Japanese Single Center #MMPMID33743048
  • Arai R; Fukamachi D; Ebuchi Y; Migita S; Morikawa T; Monden M; Takei N; Tamaki T; Kojima K; Akutsu N; Murata N; Kitano D; Okumura Y
  • Heart Vessels 2021[Oct]; 36 (10): 1474-1483 PMID33743048show ga
  • There are a few Japanese data regarding the incidence and outcomes of acute myocardial infarction (AMI) after the coronavirus disease 2019 (COVID-19) outbreak. We retrospectively reviewed the data of AMI patients admitted to the Nihon University Itabashi Hospital after a COVID-19 outbreak in 2020 (COVID-19 period) and the same period from 2017 to 2019 (control period). The patients' characteristics, time course of admission, diagnosis, and treatment of AMI, and 30-day mortality were compared between the two period-groups for both ST-segment elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI), respectively. The AMI inpatients decreased by 5.7% after the COVID-19 outbreak. There were no differences among most patient backgrounds between the two-period groups. For NSTEMI, the time from the symptom onset to admission was significantly longer, and that from the AMI diagnosis to the catheter examination tended to be longer during the COVID-19 period than the control period, but not for STEMI. The 30-day mortality was significantly higher during the COVID-19 period for NSTEMI (23.1% vs. 1.9%, P = 0.004), but not for STEMI (9.4% vs. 8.3%, P = 0.77). In conclusion, hospitalizations for AMI decreased after the COVID-19 outbreak. Acute cardiac care for STEMI and the associated outcome did not change, but NSTEMI outcome worsened after the COVID-19 outbreak, which may have been associated with delayed medical treatment due to the indirect impact of the COVID-19 pandemic.
  • |*COVID-19[MESH]
  • |Aged[MESH]
  • |Aged, 80 and over[MESH]
  • |Coronary Angiography/*trends[MESH]
  • |Female[MESH]
  • |Hospital Mortality/trends[MESH]
  • |Hospitalization/*trends[MESH]
  • |Humans[MESH]
  • |Incidence[MESH]
  • |Japan/epidemiology[MESH]
  • |Male[MESH]
  • |Middle Aged[MESH]
  • |Myocardial Infarction/diagnostic imaging/mortality/*therapy[MESH]
  • |Patient Acceptance of Health Care[MESH]
  • |Percutaneous Coronary Intervention/*trends[MESH]
  • |Retrospective Studies[MESH]
  • |Risk Assessment[MESH]
  • |Risk Factors[MESH]
  • |Time Factors[MESH]
  • |Time-to-Treatment/*trends[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box